SCHEMBL691671

SCHEMBL691671

CC(C)n1nccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11123947 0.77 ALDH1A1 (0.37)
SCHEMBL19373778 0.76
SCHEMBL11642483 0.76 MEN1 (0.46)
Hydrochloric Acid SCHEMBL17873716 0.74 POLB (0.38)
SCHEMBL1487464 0.73
SCHEMBL19737896 0.71
SCHEMBL4365364 0.71
SCHEMBL21817999 0.71
SCHEMBL22334277 0.71
SCHEMBL1628593 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US claimed
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO INC (US) 2026-03-12 US disclosed
US-20250381187-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2025-12-18 US disclosed
US-12440491-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2025-10-14 US disclosed
US-20250270213-A1 PI3Ka INHIBITORS PIKAVATION THERAPEUTICS, INC. 2025-08-28 US disclosed
CN-119654321-A PI3K alpha inhibitors 突触活化疗法股份有限公司 2025-03-18 CN disclosed
EP-4511373-A1 PI3K? INHIBITORS Synnovation Therapeutics, Inc. (US) 2025-02-26 EP disclosed
CN-119384474-A Liquid composition and optical film 日本瑞翁株式会社 2025-01-28 CN disclosed
CN-119053889-A Multilayer film, method for producing same, polarizing plate, and organic electroluminescent image display device 日本瑞翁株式会社 2024-11-29 CN disclosed
US-20240360120-A1 RAD51 INHIBITORS CYTEIR THERAPEUTICS, INC. 2024-10-31 US disclosed
CN-1552174-A Mulitilayer circuit board, resin base material, and its production method �ձ�������ʽ���� 2004-12-01 CN disclosed
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5942520-A Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines CELL PATHWAYS, INC. (US) 1999-08-24 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed
US-5488055-A ADMINISTERING GMP HOSPHODIESTERASE INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND CARDIOVASCULAR DISORDERS SANOFI WINTHROP INC. (US) 1996-01-30 US disclosed
EP-0015872-B1 CATIONIC AZODYESTUFFS, THEIR PREPARATION AND THEIR USE IN DYEING AND PRINTING TEXTILE MATERIAL CIBA-GEIGY AG (CH) 1983-03-30 EP disclosed
EP-0015872-A1 Cationic azodyestuffs, their preparation and their use in dyeing and printing textile material CIBA-GEIGY AG (CH) 1980-09-17 EP disclosed